| 摘要 |
medicine, obstetrics. SUBSTANCE: the method puts forward to apply perfluorane to be intravenously injected through infusomatic device at 50 ml/h velocity at the dosage of 3.5 ml/kg body weight, 3-4 times, not more. The method in question enables to improve uterine- placental blood flow, increase saturation of intervillous space with an oxygen to enhance activity of extravillous cytotrophoblast. Selected doses and modes enable to exclude side effects caused by perfluorane in pregnant women. EFFECT: higher efficiency of therapy. 2 ex, 10 tbl |
